MarketInOut Stock Screener Log In | Sign Up

Phaarmasia Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Phaarmasia Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization607.6 mln
Float1.45 mln

EPS

25.85
Exceptional

P / E

3.21
Deeply undervalued

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-2.36
Borderline

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.05
Debt-free

Business Description

Phaarmasia Limited is a Hyderabad-based pharmaceutical company founded in 1981 that produces a broad range of hormonal medicines, including contraceptives, fertility treatments, and hormone therapies, primarily for the Indian market. The company also sells injectable hormone products and various tablet formulations covering reproductive health, thyroid support, and muscle-related conditions. In addition to its pharmaceutical line, Phaarmasia markets a range of herbal consumer health products under the Smyle brand, including toothpaste, a cough and sore throat remedy, and a mouth ulcer gel.

Key Fundamentals

EPS25.85
P/E3.21
ROE127
RPS71.15
ROIC7.62
ROA55.21
Interest Cover8.04
EBITDA, mln218
EV / EBITDA2.31
EV / EBIT2.33
Revenue, mln486
EV / Revenue1.03

Quote Details

Last 83.00
Change -0.1 (-0.12%)
Open 83.00
Volume 9,189
Turnover 762,687
Average Volume 678.05

Financial Ratios

Pre-Tax Profit Margin44
Current Ratio3.46
Price / Book2.72
Price / Tangible Book2.72
Price / Free Cash Flow6.32
Debt / Equity0.05
Price / Sales1.24

Financial Strength

Altman Z-Score9.95
Piotroski F-Score 9 / 9
Beneish M-Score-2.36
Price to Intrinsic Value1.72
Price to Graham Number0.64
Shiller PE Ratio37.45

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.75% 90 / 100   
1 Month -6.74% 51 / 100   
2 Months -13.11% 36 / 100   
6 Months 2.65% 66 / 100   
1 Year 108% 96 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog